Liposomal Amphotericin B Injectable 50 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/vial
Reference Brands: AmBisome(US & EU)
Category: Anti-fungal
Liposomal Amphotericin B binds to fungal ergosterol, creating pores that disrupt cell membrane integrity and cause fungal cell death. It offers broad-spectrum activity, enhanced tissue penetration, and reduced toxicity compared to conventional formulations. Benefits include effective treatment of severe systemic infections with fewer side effects, improving patient outcomes.
Product Description:
Liposomal Amphotericin B is approved in the EU and US for severe fungal infections. In the EU, Gilead’s AmBisome is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA-approved AmBisome is backed by comprehensive clinical data, biosimilarity assessments, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and submissions, visit PharmaTradz. We facilitate efficient market access for Liposomal Amphotericin B, ensuring adherence to European and American standards for safe, effective antifungal therapy, reducing toxicity while maintaining efficacy in severe infections.
Liposomal Amphotericin B Injectable — third party manufacturing & bulk supply
Liposomal Amphotericin B Injectable 50 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Liposomal Amphotericin B Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Liposomal Amphotericin B Injectable →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Liposomal Amphotericin B is used to treat severe systemic fungal infections, including invasive aspergillosis, cryptococcal meningitis, mucormycosis, and systemic candidiasis. The liposomal formulation allows targeted delivery, improved tolerability, and reduced kidney toxicity compared to conventional amphotericin B.
Liposomal Amphotericin B contains amphotericin B encapsulated within liposomes made of phospholipids and cholesterol. This lipid-based structure helps the drug circulate longer in the bloodstream and reduces toxicity while maintaining strong antifungal activity.
The main trade name is AmBisome, widely used in the USA, EU, UK, and global markets.
AmBisome is manufactured by Gilead Sciences. Several other GMP-certified pharmaceutical companies also produce generic liposomal amphotericin B in different regions.
The generic name is amphotericin B (liposomal).
The primary brand name is AmBisome.
Liposomal Amphotericin B is manufactured in Gilead’s regulated facilities in the USA and Europe, along with other approved global GMP manufacturers producing generic versions for international distribution.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
